May 16, 2025
STAT cancer reporter Angus Chen looks at his tablet as panelist Clifford Hudis speaks and Karen Knudsen and Danielle Bitterman (far right) look on during the Breakthrough Summit West Wednesday in San Francisco.
Sarah Gonzales for STAT

Cancer leaders lay out an optimistic vision for how AI will enhance patient care

AI in oncology will transform cancer care, experts say, helping match patients to trials, improve outcomes, support clinician decision-making

By Jonathan Wosen


STAT+ | Reed Jobs warns Trump funding cuts will undermine research needed for cancer breakthroughs

Jobs, founder of the cancer-focused venture capital fund Yosemite, calls Trump's science cuts "a tragedy" with long-term harms.

By Mario Aguilar


STAT+ | What to know about Summit Therapeutics’ looming clinical trial readout

In this week's edition of "Adam's Biotech Scorecard," Adam offers a preview of what may be the most important study readout coming this summer.

By Adam Feuerstein



Former Theranos CEO Elizabeth Holmes and her partner, Billy Evans, who has founded a company that also touts a diagnostic blood-testing device that uses only small amounts of blood.
Philip Pacheco/Getty Images

Opinion: I was a Theranos whistleblower. Here’s what I think Elizabeth Holmes is up to

STAT First Opinion essay: Tyler Shultz says he always knew Elizabeth Holmes would have a second act, “shocked it's starting while she's still behind bars.”

By Tyler Shultz


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.